Pharmacological Management of Neurocognitive Disorders
A series of conferences on neurocognitive disorders presented by AVC-Aphasie Laval and Ï㽶ÊÓƵ
AVC-Aphasie LavalÌýis proud to announce a partnership with theÌýDementia Education ProgramÌýof the Faculty of Medicine and Health Sciences at Ï㽶ÊÓƵ. This collaboration aims to offer a series of free conferences on neurocognitive disorders.
These 45-minute lectures will be followed by a 15-minute question period. They are intended for both members of AVC-Aphasie Laval and the community. Offered in hybrid mode, it will be possible to attend via Zoom or to reserve a place on the organization's premises.
Please note that the conferences will be presented in English in the morning and in French in the afternoon.
Pharmacological Management of Neurocognitive Disorders
August 30 at 11:00 a.m. (in English) and at 1:30 p.m. (in French)
Dr. Serge Gauthier will provide up-to-date information on the medications that are used to treat neurocognitive disorders.
Lecturer:ÌýSerge Gauthier, MD, FRCPC,ÌýC.M., C.Q.
Dr. Serge Gauthier is a clinical neurologist specializing in the development of new tools for diagnosis and treatments for people living with Alzheimer’s disease. He was the Director of the Ï㽶ÊÓƵ Research Centre for Studies in Aging (MCSA) from 1986 to 1997, and Director of the Alzheimer Disease and Related Disorders Research Unit of the MCSA until 2021. He became a senior scientist of the CIHR-Rx&D program (Canadian Institutes of Health Research and Canada’s Research-Based Pharmaceutical Companies) in 1997. Dr. Gauthier is the Academic Co-Lead for the Dementia Education Program and Professor Emeritus in the Department of Neurology and Neurosurgery as well as the Department of Psychiatry at Ï㽶ÊÓƵ.ÌýHis accomplishments led to him being appointed to the Order of Canada in 2014 and the National Order of Québec in 2017.
To learn more and register for this free virtual lecture, visit the AVC-Aphasie Laval webpage:Ìý
